Gene · 3624
Papers2,354
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,354
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Activin A marks a novel progenitor cell population during fracture healing and reveals a therapeutic strategy. | Elife | 2023 | 38079220 | PubTator, text mining | PubMed |
| A Journey to Reach the Ovary Using Next-Generation Technologies. | Int J Mol Sci | 2023 | 38068916 | PubTator, text mining | PubMed |
| Identifying Predictive Biomarkers for Head and Neck Squamous Cell Carcinoma Response. | Cancers (Basel) | 2023 | 38067301 | PubTator, text mining | PubMed |
| Circular RNA CDR1as Mediated by Human Antigen R (HuR) Promotes Gastric Cancer Growth via miR-299-3p/TGIF1 Axis. | Cancers (Basel) | 2023 | 38067260 | PubTator, text mining | PubMed |
| The New Role of HNF1A-NAS1/miR-214/INHBA Signaling Axis in Colorectal Cancer. | Front Biosci (Landmark Ed) | 2023 | 38062804 | PubTator, text mining | PubMed |
| Gene expression alterations predict the pathological complete response in triple-negative breast cancer exploratory analysis of the NACATRINE trial. | Sci Rep | 2023 | 38049525 | PubTator, text mining | PubMed |
| Identification and validation of feature genes associated with M1 macrophages in preeclampsia. | Aging (Albany NY) | 2023 | 38048229 | PubTator, text mining | PubMed |
| Mapping and modeling human colorectal carcinoma interactions with the tumor microenvironment. | Nat Commun | 2023 | 38036590 | PubTator, text mining | PubMed |
| Potential Roles of Activin in Head and Neck Squamous Cell Carcinoma Progression and Mortality. | Anticancer Res | 2023 | 38030164 | PubTator, text mining | PubMed |
| The Emerging Roles of Exosomal miRNAs in Breast Cancer Progression and Potential Clinical Applications. | Breast Cancer (Dove Med Press) | 2023 | 38020052 | PubTator, text mining | PubMed |
| Understanding Solid-Based Platelet-Rich Fibrin Matrices in Oral and Maxillofacial Surgery: An Integrative Review of the Critical Protocol Factors and Their Influence on the Final Product. | Medicina (Kaunas) | 2023 | 38003952 | PubTator, text mining | PubMed |
| CD39+CD55- Fb Subset Exhibits Myofibroblast-Like Phenotype and Is Associated with Pain in Osteoarthritis of the Knee. | Biomedicines | 2023 | 38002046 | PubTator, text mining | PubMed |
| Multiple-microarray analysis for identification of key genes involved in diabetic nephropathy. | Medicine (Baltimore) | 2023 | 37986381 | PubTator, text mining | PubMed |
| Identification of tumor-agnostic biomarkers for predicting prostate cancer progression and biochemical recurrence. | Front Oncol | 2023 | 37965470 | PubTator, text mining | PubMed |
| Oncogenic KRAS, Mucin 4, and Activin A-Mediated Fibroblast Activation Cooperate for PanIN Initiation. | Adv Sci (Weinh) | 2023 | 37964407 | PubTator, text mining | PubMed |
| Analysis of Skin Regeneration and Barrier-Improvement Efficacy of Polydeoxyribonucleotide Isolated from Panax Ginseng (C.A. Mey.) Adventitious Root. | Molecules | 2023 | 37959659 | PubTator, text mining | PubMed |
| The Immunological Landscape of M1 and M2 Macrophages and Their Spatial Distribution in Patients with Malignant Pleural Mesothelioma. | Cancers (Basel) | 2023 | 37958292 | PubTator, text mining | PubMed |
| INHBA gene silencing inhibits proliferation, migration, and invasion of osteosarcoma cells by repressing TGF-β signaling pathway activation. | J Orthop Surg Res | 2023 | 37940978 | PubTator, text mining | PubMed |
| Targeting myeloid checkpoint Siglec-10 reactivates antitumor immunity and improves anti-programmed cell death 1 efficacy in gastric cancer. | J Immunother Cancer | 2023 | 37935567 | PubTator, text mining | PubMed |
| Prediction of anti-TNF therapy failure in ulcerative colitis patients by ensemble machine learning: A prospective study. | Heliyon | 2023 | 37928018 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3624/papers?page=11